BioScience Valuation (BSV) is a boutique consulting company working at the intersection of life sciences and finance. Based in the Munich metropolitan area and in Berlin, BSV operates globally and advises clients on all continents. Since 2000, the company has been at the forefront of translating scientific innovation into financial value. We assist clients in making value-driven decisions and securing the best possible deals.

What sets us apart from our competitors is our interdisciplinary team of physicians, scientists, and experts in finance and economic modeling as well as our deal-making experience. Our distinguished team members have collectively left their mark in experimental research at world-class institutions, through leading roles in Biotech and Pharma companies, and in corporate finance, venture capital and investment funds, MedTech, and data science.

As trusted partner for C-level Pharma, Biotech and MedTech executives and their investors, we advise start-ups, maturing, and fully integrated companies as well as public entities. Our evidence-based valuation approach is used to inform investment decisions, prioritize assets, optimize business strategy, and maximize exit value. We team up with our clients to support licensing deals, acquisitions, financings, investments, and IPOs.